Purchase Order HT001421P0155

Award Date 6/15/21
Potential Completion Date 6/29/26
Potential Value $170K
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions including infectious disease and genetic tests. The $36,915.00 contract is for a 5-year warranty and maintenance service on Cepheid's diagnostic equipment. There is no set-aside designation. Cepheid has received numerous other federal contracts and subcontracts to provide diagnostic testing products and support services to agencies such...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract provides for annual preventive maintenance services with a total potential value of $215,902 and a period of performance through June 30, 2027. The contract does not have a set-aside designation. Cepheid is an experienced federal contractor, having previously been awarded numerous prime contracts and...
This is a firm fixed price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide equipment maintenance and support services. The contract has a ceiling value of $139,197.26 and a period of performance through September 19, 2025. The original solicitation was a special notice that did not use a small business set-aside. Cepheid has previously received numerous prime federal contracts and subcontracts from agencies...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide annual maintenance services for GeneXpert diagnostic systems. The $161,500.00 contract has a completion date of August 28, 2027 and does not have a set-aside designation. Cepheid has received numerous other federal contract awards and grants to supply the Department of Veterans Affairs, the Defense Logistics Agency, and the...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $101,475.00, is for the provision of CEPHEID SERVICE and has an ultimate completion date of July 31, 2028. The contract does not have a set-aside designation. Cepheid, the prime contractor, is an experienced federal contractor, having been awarded numerous prime contracts and subcontracts to provide diagnostic testing...
This is a federal contract award from the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $127,000.00 firm fixed-price purchase order is for annual preventive maintenance services. The contract has an ultimate completion date of May 31, 2027 and was awarded on June 2, 2022. This appears to be part of a larger contracting vehicle, as Cepheid has been awarded several Indefinite Delivery Contracts and Blanket Purchase Agreements with the Department...
This is a federal purchase order contract awarded by the Defense Health Agency (DHA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for $85,690.44 and is for the provision of maintenance services for Cepheid's CEPHEID Analyzers. The contract has a period of performance through January 31, 2030 and is a firm fixed-price contract type. This contract does not have a set-aside designation. Cepheid is an experienced federal contractor, holding several...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, titled "ADVANTAGE PLUS MAINTENANCE AGREEMENT", has a ceiling value of $137,704.72 and an ultimate completion date of April 27, 2026. The contract does not have a set-aside designation. Cepheid is the prime contractor and is responsible for providing maintenance services for its diagnostic equipment and test...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the maintenance and service of Cepheid equipment in a laboratory. The contract has a total ceiling value of $147,250.00 and an ultimate completion date of September 30, 2027. The contract does not have a set-aside designation. Cepheid has been awarded numerous prime federal contracts to provide diagnostic testing equipment, reagents,...
The U.S. Defense Health Agency (DHA) awarded a $127,040.00 firm fixed-price purchase order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for 12 months of service and maintenance. The contract has no set-aside designation. Cepheid, a subsidiary of Danaher Corporation, has been awarded numerous prime federal contracts to provide diagnostic testing equipment, reagents, consumables, and associated maintenance and support services to various agencies, including the...

This firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The $169,860 contract is to acquire a service maintenance agreement for Walter Reed medical facilities, with a period of performance through June 29, 2026. This contract was not set aside for any specific business type.

Cepheid is an established federal contractor, holding numerous prime contracts and indefinite delivery vehicles (IDVs) with the Department of Veterans Affairs (VA) and other agencies to provide molecular diagnostic equipment, reagents, consumables, and associated maintenance and support services for clinical testing programs. The company has also participated as a subrecipient on federal grant awards, collaborating with academic partners on efforts to improve tuberculosis diagnostics globally.

Generated 8/29/24, 9:37 AM